Open-source ecosystem for in vitro and microphysiological systems
Menu

About

AboutGovernanceResponsible DataSecurity & PrivacyPolicies

Data

Data LibraryFind Data

Contribute

On-RampSubmit DataContributor MetadataDashboard

Tools

ToolsOpen SourceDevelopersSandboxGitHub

Learning & Community

Learning NetworkResourcesNews and EventsCommunityFor IndustryContact
Save the DateDecember 1-2, 2026Charlotte, North Carolina12th Annual Regenerative Manufacturing Innovation Consortium (RegMIC) Meeting: A Roadmap for Tissue Organoids and Body-on-a-Chip Manufacturing Standards
About MOSSDOAbout RegMICAbout the RegMIC 2026 meeting
Back to Home

Sandbox

Testing, Benchmarking, and Demonstration Space

Sandbox will support pilot resources, testbed activities, validity testing, benchmarking, and workflow demonstrations as the ecosystem matures.

Coming soon

Prototype workflows and testbed activities are being prepared

The sandbox will provide a controlled space for demonstration datasets, workflow testing, benchmarking concepts, and validation pilots that support the broader PhysioVerse mission.

Demonstration datasets

Curated example records that help contributors and users understand submission, discovery, and review workflows.

Coming soon

Tool testing

A place to evaluate validation utilities, metadata checks, catalog features, and workflow components before broader release.

Coming soon

Benchmarking pilots

Future activities for comparing descriptors, model outputs, file relationships, and review readiness across representative use cases.

Coming soon

Standards and manufacturing partners

MOSSDO and RegMIC

Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.

About MOSSDO

The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.

About RegMIC

The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.